Search research articles
Contact Us
Filters
Showing results (1-10 of 88) with videos related to
Page
of 9
Sort By:
Expert Opinion on Drug Safety
|
December 24, 2005
Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs
Marc Maillard, Michel Burnier
Expert Review of Cardiovascular Therapy
|
May 14, 2005
Telmisartan/hydrochlorothiazide: a new fixed dose combination
Marc Maillard, Michel Burnier
Current Hypertension Reports
|
July 8, 2003
Recent clinical trials with omapatrilat: new developments
Anne Zanchi, Marc Maillard, Michel Burnier
Current Drug Targets. Cardiovascular & Haematological Disorders
|
February 22, 2005
The future of angiotensin II inhibition in cardiovascular medicine
Pascal Meier, Marc Maillard, Michel Burnier
Current Hypertension Reports
|
April 8, 2006
Proximal tubular function and salt sensitivity
Michel Burnier, Murielle Bochud, Marc Maillard
Seminars in Nephrology
|
September 18, 2007
Renal sodium handling and nighttime blood pressure
Michel Burnier, Lionel Coltamai, Marc Maillard, et al.
Journal of Hypertension
|
January 28, 2010
Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans
Lionel Coltamai, Marc Maillard, Alexandra Simon, et al.
Journal of Hypertension
|
August 27, 2002
Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population
Pascal Vuilleumier, Dumeng Decosterd, Marc Maillard, et al.
Journal of Hypertension
|
May 29, 2004
Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent
Catherine Falconnet, Murielle Bochud, Pascal Bovet, et al.
Kidney International
|
July 15, 2005
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men
Grégoire Wuerzner, Arnaud Chiolero, Marc Maillard, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 88) with videos related to
Sort By:
Page
of 9
Expert Opinion on Drug Safety
|
December 24, 2005
Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs
Marc Maillard, Michel Burnier
Expert Review of Cardiovascular Therapy
|
May 14, 2005
Telmisartan/hydrochlorothiazide: a new fixed dose combination
Marc Maillard, Michel Burnier
Current Hypertension Reports
|
July 8, 2003
Recent clinical trials with omapatrilat: new developments
Anne Zanchi, Marc Maillard, Michel Burnier
Current Drug Targets. Cardiovascular & Haematological Disorders
|
February 22, 2005
The future of angiotensin II inhibition in cardiovascular medicine
Pascal Meier, Marc Maillard, Michel Burnier
Current Hypertension Reports
|
April 8, 2006
Proximal tubular function and salt sensitivity
Michel Burnier, Murielle Bochud, Marc Maillard
Seminars in Nephrology
|
September 18, 2007
Renal sodium handling and nighttime blood pressure
Michel Burnier, Lionel Coltamai, Marc Maillard, et al.
Journal of Hypertension
|
January 28, 2010
Comparative vascular and renal tubular effects of angiotensin II receptor blockers combined with a thiazide diuretic in humans
Lionel Coltamai, Marc Maillard, Alexandra Simon, et al.
Journal of Hypertension
|
August 27, 2002
Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population
Pascal Vuilleumier, Dumeng Decosterd, Marc Maillard, et al.
Journal of Hypertension
|
May 29, 2004
Gender difference in the response to an angiotensin-converting enzyme inhibitor and a diuretic in hypertensive patients of African descent
Catherine Falconnet, Murielle Bochud, Pascal Bovet, et al.
Kidney International
|
July 15, 2005
Metoprolol prevents sodium retention induced by lower body negative pressure in healthy men
Grégoire Wuerzner, Arnaud Chiolero, Marc Maillard, et al.
Page
of 9